Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Burris, Howard A 3rd"'
Autor:
Garrido-Laguna I; Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Krop I; Department of Medical Oncology, Dana-Farber Cancer Center/Brigham and Women's Hospital, Boston, MA., Burris HA 3rd; Department of Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN., Hamilton E; Department of Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN., Braiteh F; Department of Medical Oncology, Comprehensive Cancer Centers of Nevada and University of Nevada Las Vegas School of Medicine, Las Vegas, NV., Weise AM; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI., Abu-Khalaf M; Department of Breast Medical Oncology, Thomas Jefferson University, Philadelphia, PA., Werner TL; Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Pirie-Shepherd S; Pfizer Inc., Oncology, San Diego, CA., Zopf CJ; Pfizer Inc., Oncology, San Diego, CA., Lakshminarayanan M; Pfizer Inc., Oncology, San Diego, CA., Holland JS; Pfizer Inc., Oncology, San Diego, CA., Baffa R; Pfizer Inc., Oncology, San Diego, CA., Hong DS; Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX.
Publikováno v:
International journal of cancer [Int J Cancer] 2019 Oct 01; Vol. 145 (7), pp. 1798-1808. Date of Electronic Publication: 2019 Feb 23.